Richard Dutton to Cytotoxicity, Immunologic
This is a "connection" page, showing publications Richard Dutton has written about Cytotoxicity, Immunologic.
Connection Strength
0.127
-
Hollenbaugh JA, Reome J, Dobrzanski M, Dutton RW. The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysis. J Immunol. 2004 Aug 01; 173(3):1738-43.
Score: 0.054
-
Dobrzanski MJ, Reome JB, Hollenbaugh JA, Dutton RW. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses. J Immunol. 2004 Feb 01; 172(3):1380-90.
Score: 0.052
-
Yeh N, Glosson NL, Wang N, Guindon L, McKinley C, Hamada H, Li Q, Dutton RW, Shrikant P, Zhou B, Brutkiewicz RR, Blum JS, Kaplan MH. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol. 2010 Aug 15; 185(4):2089-98.
Score: 0.020